Osteoporosis: who needs a bone density test?

Published: 1 October 2026 10 min read Dr. Shimaa Sherif

Medically reviewed by: Dr. Mohab Ashraf Fouad

This article was translated into English from the Arabic original and reviewed for medical accuracy.

Article illustration: Osteoporosis: who needs a bone density test?

Osteoporosis is not osteoarthritis

People often use “osteoporosis” and “osteoarthritis” as though they describe the same problem, but the distinction matters. Osteoporosis is a disease in which bone mineral density or bone mass falls, or bone structure and strength change, increasing the likelihood of fracture. Osteoarthritis affects a joint itself: cartilage and other tissues within the joint change over time, commonly producing pain, stiffness, and limited movement in the knee, hip, or hand. Knee pain with movement may therefore point toward an osteoarthritis assessment, while osteoporosis can be present without joint pain at all [1, 5, 8].

Osteoporosis is often called a silent disease because a person may notice nothing before a fracture occurs. Osteoporosis-related fractures commonly affect the vertebrae, hip, and wrist, and may follow a minor fall or stress that healthier bone would usually tolerate. An absence of pain does not prove that bone density is healthy, and general pain does not diagnose osteoporosis. Diagnosis and risk assessment depend on medical history, risk factors, and sometimes bone-density measurement rather than pain alone [1, 8, 12].

Separating the two conditions avoids investigations or treatments aimed at the wrong problem. Ordinary joint imaging can help a clinician assess osteoarthritis changes, while a bone-density test has a different purpose: measuring mineral density and helping estimate fracture risk. A person can have both conditions at the same time, but each requires its own assessment and evidence-based plan [2, 5].

Who has a higher likelihood of osteoporosis and fracture?

Age and menopause are major factors because bone loss rises with age, and women lose bone more rapidly during the first years after menopause. Osteoporosis is not limited to women, however; men can also develop it, and their risk rises as they age. A small body frame or low body weight, a family history of osteoporosis or parental hip fracture, and a previous fracture after a minor fall are all relevant details when a clinician assesses fracture risk [1, 8, 11].

Other important factors include smoking, chronic heavy alcohol use, physical inactivity, certain hormonal disorders, malabsorption conditions, and inflammatory diseases. Some medicines can increase bone loss; prolonged use of systemic glucocorticoids is an important example. This is not a reason to stop prescribed medicine on your own. Instead, tell the clinician the medicine name, dose, and duration so they can decide whether earlier bone assessment or additional protection is appropriate [1, 4, 11, 12].

One risk factor does not prove that osteoporosis is present, and having no obvious factor does not offer complete reassurance. The assessment combines age, sex, menopausal status, previous fractures, medicines, associated conditions, weight, smoking and alcohol history, and sometimes a formal fracture-risk calculator. That structured picture guides whether DXA is useful now, rather than scanning everyone because they are worried or waiting until a first fracture occurs [3, 4].

Who needs fracture-risk assessment or DXA?

There is no single worldwide age threshold that applies to everyone because guidance varies by issuing body and healthcare setting. The US Preventive Services Task Force recommends screening women aged 65 years or older and postmenopausal women younger than 65 who have one or more risk factors, using a clinical risk-assessment approach to identify increased risk. It concludes that current evidence is insufficient to recommend universal screening for asymptomatic men. This preventive recommendation applies to people without known osteoporosis or fragility fracture and does not cover secondary osteoporosis or chronic medicines associated with bone loss [3].

UK NICE guidance follows a different pathway. It advises fracture-risk assessment for all women aged 65 or older and men aged 75 or older, and for younger adults when risk factors are present. Routine assessment below age 50 is generally reserved for major factors such as a previous fragility fracture, untreated premature menopause, or current or frequent recent systemic glucocorticoid use. NICE usually begins with FRAX or QFracture and then considers DXA when the estimated risk is near a treatment threshold where the result could change management. Risk assessment and ordering a scan are therefore not always the same step [4].

These frameworks are not necessarily contradictory; each defines its population and context. In practice, a fracture after minor trauma, glucocorticoid use, noticeable height loss, premature menopause, or several combined factors deserves an earlier conversation with a clinician even below general screening ages. The clinician chooses the pathway appropriate to the local setting and individual history rather than relying on an isolated birthday [1, 3, 4].

How DXA is performed and what the result means

DXA, also written DEXA, is the most commonly used test for bone mineral density. It uses a low level of x-rays and usually measures the hip and spine because these sites are important for estimating fracture risk. The procedure is quick, non-invasive, and requires no injection; you lie on a padded table while the scanner passes over the area. Portable heel or wrist testing can provide preliminary information, but central DXA at the hip and spine is generally more useful for diagnosis and treatment monitoring [1, 2, 9].

A report commonly gives a T-score for a postmenopausal woman or a man aged 50 years or older. According to NIAMS, a score of -1 or higher falls in the healthy range, a score between -1 and -2.5 indicates low bone density called osteopenia, and a score of -2.5 or lower may indicate osteoporosis. In younger people, a Z-score may be reported, comparing density with people of the same age and sex rather than with the average healthy young adult [2].

The number should not be interpreted in isolation. Treatment decisions also consider age, previous fractures, other risk factors, and sometimes an estimate of absolute fracture risk. Osteopenia does not mean progression to osteoporosis is inevitable, and a result in the healthy range is not permission to neglect activity or nutrition. Repeat testing also has no single interval for everyone; the clinician bases timing on the result, changes in risk factors, and the management plan rather than repeating it simply because another year has passed [2, 4, 8, 10].

The scan is one part of assessment, not the whole assessment

Before ordering a scan, a clinician asks about previous fractures and how they happened, current and past medicines, chronic conditions, smoking and alcohol, nutrition and activity, and any family history of osteoporosis or parental hip fracture. For women, menstrual and menopause history is relevant. The physical examination may include height and weight, spinal posture, gait and balance, and muscle strength. These details help interpret DXA and identify fall risks or possible secondary causes needing further assessment [1].

An ordinary blood test does not measure bone density, and a normal blood calcium result does not exclude osteoporosis. Bone-density testing measures minerals within bone, while laboratory tests, when selected by the clinician, investigate a deficiency or associated condition that could affect bone or alter management. The popular search phrase “osteoporosis analysis” therefore usually refers to DXA rather than one blood sample that returns a simple positive or negative result [1, 2].

After a fragility fracture, assessment should not end with pain control or fracture healing. A fracture after minor trauma can signal a higher likelihood of another fracture and the need for a combined bone-health and fall-prevention plan. Similarly, when glucocorticoid treatment is necessary for another disease, the choice is not simply between treating that disease and protecting bone; the clinician reviews risk and balances both plans without abruptly stopping the glucocorticoid [1, 4, 10, 12].

Calcium and vitamin D: a nutritional foundation, not one prescription for everyone

Bone needs a balanced diet containing calcium and vitamin D, and vitamin D helps the body absorb calcium. A practical starting point is reviewing food intake: dairy foods when suitable, fortified alternatives, and varied dietary sources selected for the person’s health and needs. Nutrition is one part of protecting bone alongside activity, avoiding smoking, and limiting alcohol; it is not a stand-alone cure [1, 8, 10].

Supplements are not automatically necessary for everyone, and there is no single dose for all ages and circumstances. If diet does not provide enough, vitamin D is deficient, or a medical condition affects absorption, a clinician can decide whether a supplement is appropriate and select its type and amount. Taking calcium or vitamin D blindly neither diagnoses osteoporosis nor replaces prescribed osteoporosis treatment for someone at high fracture risk. Supplements can also interact with medicines, so the clinician should know everything being taken [1, 10].

With a low DXA result, the useful question is not simply, “Should I take calcium?” It is, “How much calcium and vitamin D do I obtain from food, is there a deficiency or secondary cause, and what is my overall fracture risk?” The answer distinguishes a person who needs dietary adjustment from one who needs a targeted supplement or osteoporosis medicine in addition to nutrition. This produces an individual plan based on actual risk instead of a generic online prescription [2, 10].

Protecting bone also means strengthening muscle and reducing falls

Fracture prevention depends on more than bone density. Weight-bearing activity such as walking, resistance exercise, and balance training help maintain bone and muscle and improve balance. Stronger muscles and better coordination reduce the likelihood of falling, which is particularly important with age. If osteoporosis, a vertebral fracture, or limited mobility is already present, exercise type and intensity should be selected with a clinician or rehabilitation professional because sudden or excessive loading is not appropriate for everyone [1, 6].

The home is also part of prevention: provide good lighting, remove loose rugs and cables from walking routes, clean spills promptly, use secure stair rails, and wear supportive footwear. Reviewing vision and hearing, rising slowly when dizziness occurs, and asking for a review of medicines that may cause sleepiness or poor balance are practical ways to reduce falls. The aim is not to become afraid of movement; it is to move safely in a supportive environment [7, 8, 12].

Preserving muscle also matters, particularly during weight loss or reduced appetite. Adequate protein for the individual and progressive resistance activity can support strength and mobility, although details may differ with kidney disease or another medical condition. A successful prevention plan combines suitable nutrition, safe movement, reduced fall hazards, and prescribed medicine when indicated; no single component replaces all the others [1, 6, 10].

When prompt assessment is needed and what comes next

New severe back pain after a minor movement, noticeable loss of height, or a new change in spinal posture deserves prompt assessment because vertebral fracture can present this way. After a fall, severe hip pain or inability to stand or bear weight on the leg requires urgent care to check for a hip fracture. A fracture after minor trauma is also a reason to review bone health and future fracture risk rather than treating only the current injury [1, 8, 12, 13].

When there is no urgent injury but risk factors are present, prepare a list of medicines and supplements, previous fractures, menopause history, and any parental hip fracture. Ask first about fracture-risk assessment and whether DXA would add information that changes a decision. If a scan is requested, its discussion should cover the appropriate T-score or Z-score, other risk factors, and a plan for movement, nutrition, and fall prevention rather than handing over an unexplained number [1, 2, 4].

The medical team at La Rose can review risk factors, identify the appropriate next clinical step, and direct you to a DXA provider if scanning is indicated; this article does not imply that a DXA scanner is available inside the clinic. You can book a consultation with the medical team at La Rose branches in Maadi or Fifth Settlement, New Cairo, for a calm, structured assessment based on your circumstances [1, 4].

Knowledge Centre

How this article was reviewed

This content is for health education and does not replace diagnosis or an individual care plan.

Author listed in record
Dr. Shimaa Sherif
Reviewer listed in record
Dr. Mohab Ashraf Fouad
Linked medical sources
13
Publication and review history
  1. Published: 1 October 2026
  2. 1 October 2026: We reviewed the article and updated its information for 2026.
  3. Review record: A reviewer is listed in the publication record
  4. Linked medical sources: 13

Frequently asked questions

No single blood test measures bone density or returns a simple positive or negative osteoporosis diagnosis. The usual measurement is central DXA of the hip and spine. A clinician may order blood tests to look for deficiencies or associated conditions affecting bone, but a normal blood calcium result does not rule out osteoporosis [1, 2].

It depends on the guideline and clinical context. USPSTF recommends screening women aged 65 or older and postmenopausal women younger than 65 when clinical assessment identifies increased risk. NICE recommends risk assessment for all women from 65 and men from 75, plus younger adults with risk factors, followed by DXA when it could change a decision. Previous fragility fracture, prolonged glucocorticoid use, or premature menopause justify an earlier discussion [3, 4].

Osteoporosis is usually silent and may cause no pain before a fracture. A vertebral fracture may present with severe back pain, height loss, or a stooped posture. Joint pain with movement more often points toward a condition such as osteoarthritis and needs its own assessment; pain alone neither confirms nor excludes osteoporosis [1, 5, 8].

For T-scores, a result from -1 down to above -2.5 indicates low bone density called osteopenia, while -2.5 or lower may indicate osteoporosis. The clinician does not make a treatment decision from this number alone; age, previous fractures, and other risk factors are considered as well [2, 10].

Calcium and vitamin D are important to bone health, but they are not an automatic substitute for osteoporosis medicine in someone at high fracture risk. Assessment starts with diet and actual need, after which a clinician decides whether a supplement or specific treatment is indicated. Avoid unsupervised doses, especially when taking other medicines or living with chronic disease [1, 10].

Men can develop osteoporosis, but universal screening recommendations differ. USPSTF finds the evidence insufficient to recommend screening all asymptomatic men, while NICE recommends fracture-risk assessment for all men from age 75 and for younger men with risk factors. A previous fragility fracture, glucocorticoid exposure, or low weight makes an individual discussion important regardless of age [1, 3, 4].

Written by

Dr. Shimaa Sherif

Specialist in Rheumatology, Joint Diseases, Physical Medicine and Rehabilitation

  • Specialist in rheumatology, joint diseases, physical medicine and rehabilitation
  • MSc in Rheumatology and Rehabilitation
  • Extensive experience in diagnosing and treating rheumatic diseases

Dr. Shimaa Sherif is a specialist in rheumatology, joint diseases, physical medicine and rehabilitation, with an MSc in Rheumatology and Rehabilitation and extensive experience in diagnosing and treating rheumatic diseases. She follows rheumatoid arthritis, lupus, joint and spinal osteoarthritis, gout and fibromyalgia, as well as scleroderma, Sjögren's syndrome and Behçet's disease. She also follows pregnancy in patients with rheumatoid arthritis and provides rehabilitation and physical medicine for joint patients.

View profile

You may also find helpful

Start with a real consultation - book now

Booking ahead is required. Patients are seen in order of arrival.